(Q73046518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alpha (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

chronic myeloid leukemia

1 reference

J L Steegmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M J Requena

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Martín-Regueira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

R De La Cámara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F Casado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F Rodriguez Salvanés

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J M Fernández Rañada

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Hematology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

170-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

31 October 2019

cites work

1 reference

Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service

21 January 2018

1 reference

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

21 January 2018

1 reference

Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia

21 January 2018

1 reference

Autoantibodies during alpha-interferon therapy for chronic hepatitis B

21 January 2018

1 reference

Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha

21 January 2018

1 reference

Drugs recently associated with lupus syndromes

21 January 2018

1 reference

Cutaneous sarcoidosis in a patient with Philadelphia-positive chronic myelogenous leukemia treated with interferon-alpha

21 January 2018

1 reference

Psoriasis and alpha-interferon

21 January 2018

1 reference

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

21 January 2018

1 reference

Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems

21 January 2018

1 reference

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

21 January 2018

1 reference

Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia

21 January 2018

1 reference

Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic response

21 January 2018

1 reference

Chronic myelogenous leukemia complicated by autoimmune hemolytic anemia

21 January 2018

1 reference

Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies

21 January 2018

1 reference

Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia.

21 January 2018

1 reference

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors

21 January 2018

1 reference

Autoimmune diseases: the failure of self tolerance

21 January 2018

1 reference

Diagnostic significance of thyroid microsomal antibodies in randomly selected population

21 January 2018

1 reference

The direct antiglobulin test is frequently positive in chronic myeloid leukemia patients treated with interferon-alpha

21 January 2018

1 reference

Low-titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.10282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605388%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference